MET and neoplasm: The cMET pathway is a likely mechanism exploited by cancer cells to escape from antiangiogenic therapy.[22] The hypoxic tumor microenvironment stimulates MET expression, which increases tumor invasion and metastasis after selective inhibition of VEGF signaling.